Revenues for the period were £70.3mln, up 28% on a constant currency basis, or an organic 10% if the impact of recent purchases was stripped out.
Full interview: Alliance Pharma delivers 'solid' first-half performance with strong cashflow
Quick facts: Alliance Pharma PLC
Price: 71 GBX
Market Cap: £368.89 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Alliance Pharma PLC named herein, including the promotion by the Company of Alliance Pharma PLC in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE